Effective immunotherapy for HPV associated cervical cancer precursor lesions

预防宫颈癌的疫苗目前正在开发中。这些药物将用于预防感染致病病毒--乳头瘤病毒。然而，世界上已经有很多人已经感染了乳头瘤病毒，在未来30年的任何时候，这种病毒都可能转变为癌症。因此，需要一种可以与预防性疫苗一起接种的疫苗，这种疫苗可以治疗现有的感染。这项研究阐述了治疗现有乳头瘤病毒感染所需的免疫反应的特点，因为这一点目前尚不清楚。

Vaccines to prevent cervical cancer are currently being developed. These will be used to prevent infection with the causal virus, papillomavirus. However, there are very many people world wide who already have papillomavirus infection, which could turn into cancer at any point over the next 30 years. Therefore, there is a need for a vaccine that could be given along with the preventative vaccine, which would treat existing infections. This study addresses the characteristics of the immune response required to treat existing papillomavirus infections, since this is not currently known.